Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

University of Nouakchott | Mauritania

Author Profile

Scopus

ORCID ID

Dr. Mohamed Lemine Cheikh Brahim Ahmed

🎓Education :

  • PhD in Public Health 🧬
    Université Mohammed V, Rabat, Morocco
  • Master of Public Health in Molecular Epidemiology of Zoonotic Diseases 🦠🔬
    IAV Hassan II, Rabat, Morocco
  • Certificate in Molecular Biology and Bioinformatics 🧬💻
    Hua Zhong Normal University, Wuhan, China

🌍Professional Memberships :

  • Member of the World Society for Virology (WSV) 🧫
  • Member of the International Covid-19 Research Network (ICRN) 🦠
  • Member of the One Health Heukelbach Institute 🌱
  • Member of the MENA Coalition for HPV Elimination 💉
  • Member of the Research Unit on Molecular Epidemiology and Microorganism Diversity (EMDM) 🧬
  • President of the Mauritanian Society for Scientific Research (AMDRS) 🧑‍🔬
  • Collaborator on the Global Burden of Diseases (GBD) project, Institute for Health Metrics and Evaluation, University of Washington 🌎

💡Key Skills :

  • Vaccine Coordination & Logistics 🚚💉:

  • Planned and supervised vaccine logistics for remote regions in Mauritania, ensuring stock management and quality control practices for vaccines like PCV13 and Rotarix.
  • Public Health Communication & Training 📢👩‍⚕️:

  • Conducted team-building and training sessions for local health personnel, focusing on routine and Covid-19 vaccination campaigns.
  • Research Project Management 🧑‍🔬📊:

  • Led public health research projects, managing performance indicators, and reporting on vaccine distribution and health systems.
  • Flexibility & Versatility ⚙️:

  • Adapted to various challenges in vaccine distribution and epidemiological surveillance, especially during pandemics.

Main Qualifications :

Vaccination 💉:

  • Supervised and trained local teams for stock management and quality control of vaccines across remote areas in Mauritania.
  • Led national Covid-19 vaccination strategy development, training teams and evaluating the impact of vaccine introductions (e.g., PCV13, Rotarix).
  • Coordinated routine vaccination campaigns across all 15 regions of Mauritania and introduced critical vaccines like nVPO2 for polio.

Epidemiological Surveillance 🧬:

  • Developed and implemented national strategies for combatting Covid-19, including plans for testing diseases like measles, polio, hemorrhagic fevers, and HPV.
  • Organized and led sentinel surveillance programs for diseases like rotavirus and influenza.
  • Conducted performance evaluations of Mauritania’s health information systems and trained response teams for integrated epidemiological surveillance.

🏢Recent Professional Experience :

National Consultant

UNICEF, Mauritania (Feb 2022 – Jul 2022)
Supported cold chain logistics and vaccine management for poliomyelitis response campaigns. Key tasks included overseeing vaccine distribution, supporting data analysis, and participating in meetings for budget planning with GPEI.

  • Provided technical assistance for vaccine logistics, ensuring the collection and destruction of unusable vaccine vials.
  • Led training sessions for independent monitors and LQAS surveyors to evaluate the polio vaccination campaign.

📈 Conclusion🌟

Dr. Mohamed Lemine Cheikh Brahim Ahmed is a highly skilled expert in vaccination logistics and epidemiological surveillance 🦠💉, with extensive experience in public health, research management, and disease control. His work spans from developing national vaccination strategies, including Covid-19, to training teams and overseeing campaigns in remote regions of Mauritania. As a member of numerous global health organizations 🌍 and a key contributor to projects like the Global Burden of Diseases 🌎, he is committed to improving public health outcomes through innovative approaches and evidence-based strategies. Dr. Ahmed’s versatility, leadership, and dedication make him a valuable asset in the field of global health and vaccination efforts.

📊🔬NOTABLE PUBLICATION:

 

    • Article: Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis
      • Authors: Abou Ghayda, R., Lee, K.H., Han, Y.J., Smith, L., Shin, J.I.
      • Journal: Journal of Medical Virology
      • Year: 2022

     

    • Article: Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
      • Authors: Park, S.H., Hong, S.H., Kim, K., Il Shin, J., Smith, L.
      • Journal: Journal of Medical Virology
      • Year: 2023

     

    • Article: COVID-19 outbreak in Mauritania: Epidemiology and health system response
      • Authors: Ahmed, M.L.C.B., Zehaf, S., El Alem, M.M., Abdellahi, M.V.M., Heukelbach, J.
      • Journal: Journal of Infection in Developing Countries
      • Year: 2021

Cancer Research and Advocacy

Cancer Research and Advocacy

Introduction: Cancer Research and Advocacy stand as pillars in the global effort to combat cancer, addressing both the scientific exploration of this complex disease and the vital support and awareness needed for patients and their families. Together, they strive to improve prevention, early detection, and treatment while championing the rights and well-being of those affected by cancer.

Subtopics in Cancer Research and Advocacy:

Advancements in Cancer Research: Dive into the latest breakthroughs in cancer research, including novel treatment modalities, understanding cancer genetics, and exploring emerging technologies like artificial intelligence in cancer diagnosis and prognosis.

Patient-Centric Care: Explore the advocacy efforts focused on ensuring patients receive the best possible care, including initiatives to enhance access to treatment, improve patient outcomes, and promote a patient-centered healthcare system.

Early Detection and Screening: Investigate the critical role of early detection in cancer survival rates and advocacy campaigns aimed at raising awareness about the importance of regular screenings and diagnostic tools.

Cancer Prevention and Education: Examine initiatives and programs that educate the public about risk factors, lifestyle choices, and preventive measures to reduce the incidence of cancer.

Support and Survivorship: Learn about the various support networks, survivorship programs, and advocacy efforts dedicated to enhancing the quality of life for cancer survivors and their families, addressing emotional, psychological, and practical needs.

Policy and Legislation: Delve into the advocacy work related to cancer-related policies, funding for research, and healthcare legislation, as well as the impact of these policies on cancer patients and research institutions.

Clinical Trials and Access: Explore how advocacy groups work to improve access to clinical trials, promote transparency in research, and advocate for equitable distribution of innovative cancer therapies.

Global Initiatives: Discover international collaborations and organizations dedicated to advancing cancer research and advocacy efforts on a global scale, addressing disparities in cancer care and research across different regions.

Public Awareness Campaigns: Investigate the effectiveness of public awareness campaigns in raising funds, fostering empathy, and reducing stigma associated with cancer, and how these campaigns drive support for research and patient care.

Survivor and Patient Advocacy: Highlight the role of individuals who have experienced cancer firsthand in advocating for policy changes, increased research funding, and improved patient care, and their impact on the cancer community.